Currently holds a position at Novavax Inc
Position | Company | Period |
---|---|---|
Senior Vice President, General Counsel, Corporate Secretary | Novavax Inc | June 1, 2014 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2022-01-05 | 2022-01-03 |
Novavax Inc
(NVAX)
|
PS Planned sale |
100
-2.5%
144.4314,443 USD |
100 -2.5% | 144.43 | 14,443 USD | |
2022-01-05 | 2022-01-03 |
Novavax Inc
(NVAX)
|
PS Planned sale |
1,003
-20.3%
143.64144,070 USD |
1,003 -20.3% | 143.64 | 144,070 USD | |
2022-01-05 | 2022-01-03 |
Novavax Inc
(NVAX)
|
PS Planned sale |
800
-13.9%
142.65114,117 USD |
800 -13.9% | 142.65 | 114,117 USD | |
2022-01-05 | 2022-01-03 |
Novavax Inc
(NVAX)
|
PS Planned sale |
800
-12.2%
141.69113,350 USD |
800 -12.2% | 141.69 | 113,350 USD | |
2022-01-05 | 2022-01-03 |
Novavax Inc
(NVAX)
|
PS Planned sale |
500
-7.1%
140.0570,026 USD |
500 -7.1% | 140.05 | 70,026 USD | |
2022-01-05 | 2022-01-03 |
Novavax Inc
(NVAX)
|
PS Planned sale |
997
-12.4%
139.08138,660 USD |
997 -12.4% | 139.08 | 138,660 USD | |
2022-01-05 | 2022-01-03 |
Novavax Inc
(NVAX)
|
PS Planned sale |
400
-4.7%
137.8555,140 USD |
400 -4.7% | 137.85 | 55,140 USD | |
2022-01-05 | 2022-01-03 |
Novavax Inc
(NVAX)
|
PS Planned sale |
400
-4.5%
136.8254,728 USD |
400 -4.5% | 136.82 | 54,728 USD | |
2021-12-22 | 2021-12-20 |
Novavax Inc
(NVAX)
|
PS Planned sale |
5,000
-56.5%
230.001,150,000 USD |
5,000 -56.5% | 230.00 | 1,150,000 USD | |
2021-12-03 | 2021-12-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
366
-11.7%
202.3674,064 USD |
366 -11.7% | 202.36 | 74,064 USD | |
2021-12-03 | 2021-12-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
300
-8.8%
200.9260,276 USD |
300 -8.8% | 200.92 | 60,276 USD | |
2021-12-03 | 2021-12-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
300
-8.1%
199.8159,944 USD |
300 -8.1% | 199.81 | 59,944 USD | |
2021-12-03 | 2021-12-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
400
-9.7%
198.3579,340 USD |
400 -9.7% | 198.35 | 79,340 USD | |
2021-12-03 | 2021-12-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
300
-6.8%
197.1959,156 USD |
300 -6.8% | 197.19 | 59,156 USD | |
2021-12-03 | 2021-12-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
943
-17.6%
196.11184,932 USD |
943 -17.6% | 196.11 | 184,932 USD | |
2021-12-03 | 2021-12-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
900
-14.4%
194.54175,085 USD |
900 -14.4% | 194.54 | 175,085 USD | |
2021-12-03 | 2021-12-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
800
-11.3%
193.79155,034 USD |
800 -11.3% | 193.79 | 155,034 USD | |
2021-12-03 | 2021-12-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
691
-8.9%
192.64133,113 USD |
691 -8.9% | 192.64 | 133,113 USD | |
2021-12-01 | 2021-11-29 |
Novavax Inc
(NVAX)
|
PS Planned sale |
5,000
-64.4%
228.721,143,600 USD |
5,000 -64.4% | 228.72 | 1,143,600 USD | |
2021-11-05 | 2021-11-03 |
Novavax Inc
(NVAX)
|
PS Planned sale |
5,000
-64.4%
200.001,000,000 USD |
5,000 -64.4% | 200.00 | 1,000,000 USD | |
2021-11-03 | 2021-11-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
157
-5.4%
173.1527,185 USD |
157 -5.4% | 173.15 | 27,185 USD | |
2021-11-03 | 2021-11-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
300
-9.3%
172.4451,733 USD |
300 -9.3% | 172.44 | 51,733 USD | |
2021-11-03 | 2021-11-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
500
-13.5%
170.8885,441 USD |
500 -13.5% | 170.88 | 85,441 USD | |
2021-11-03 | 2021-11-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
200
-5.1%
169.0533,809 USD |
200 -5.1% | 169.05 | 33,809 USD | |
2021-11-03 | 2021-11-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
400
-9.3%
168.3267,328 USD |
400 -9.3% | 168.32 | 67,328 USD | |
2021-11-03 | 2021-11-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
200
-4.4%
167.1533,429 USD |
200 -4.4% | 167.15 | 33,429 USD | |
2021-11-03 | 2021-11-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
200
-4.2%
165.6733,133 USD |
200 -4.2% | 165.67 | 33,133 USD | |
2021-11-03 | 2021-11-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
300
-6.0%
164.0249,205 USD |
300 -6.0% | 164.02 | 49,205 USD | |
2021-11-03 | 2021-11-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
100
-2.0%
162.6916,269 USD |
100 -2.0% | 162.69 | 16,269 USD | |
2021-11-03 | 2021-11-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
400
-7.3%
162.1064,840 USD |
400 -7.3% | 162.10 | 64,840 USD | |
2021-11-03 | 2021-11-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
343
-5.9%
159.9054,847 USD |
343 -5.9% | 159.90 | 54,847 USD | |
2021-11-03 | 2021-11-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
400
-6.4%
158.5463,414 USD |
400 -6.4% | 158.54 | 63,414 USD | |
2021-11-03 | 2021-11-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
800
-11.3%
157.42125,936 USD |
800 -11.3% | 157.42 | 125,936 USD | |
2021-11-03 | 2021-11-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
300
-4.1%
155.9646,788 USD |
300 -4.1% | 155.96 | 46,788 USD | |
2021-11-03 | 2021-11-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
400
-5.2%
155.1662,065 USD |
400 -5.2% | 155.16 | 62,065 USD | |
2021-10-05 | 2021-10-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
48
-1.7%
190.639,150 USD |
48 -1.7% | 190.63 | 9,150 USD | |
2021-10-05 | 2021-10-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
300
-9.7%
189.6856,905 USD |
300 -9.7% | 189.68 | 56,905 USD | |
2021-10-05 | 2021-10-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
100
-3.1%
181.3618,136 USD |
100 -3.1% | 181.36 | 18,136 USD | |
2021-10-05 | 2021-10-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
352
-9.9%
179.2763,103 USD |
352 -9.9% | 179.27 | 63,103 USD | |
2021-10-05 | 2021-10-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
600
-14.4%
178.00106,798 USD |
600 -14.4% | 178.00 | 106,798 USD | |
2021-10-05 | 2021-10-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
500
-10.7%
177.0288,509 USD |
500 -10.7% | 177.02 | 88,509 USD | |
2021-10-05 | 2021-10-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
500
-9.7%
175.9187,953 USD |
500 -9.7% | 175.91 | 87,953 USD | |
2021-10-05 | 2021-10-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
400
-7.2%
174.7469,895 USD |
400 -7.2% | 174.74 | 69,895 USD | |
2021-10-05 | 2021-10-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
400
-6.7%
173.8369,530 USD |
400 -6.7% | 173.83 | 69,530 USD | |
2021-10-05 | 2021-10-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
200
-3.2%
172.4634,492 USD |
200 -3.2% | 172.46 | 34,492 USD | |
2021-10-05 | 2021-10-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
600
-8.9%
171.60102,960 USD |
600 -8.9% | 171.60 | 102,960 USD | |
2021-10-05 | 2021-10-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
200
-2.9%
169.1733,834 USD |
200 -2.9% | 169.17 | 33,834 USD | |
2021-10-05 | 2021-10-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
300
-4.1%
168.0350,410 USD |
300 -4.1% | 168.03 | 50,410 USD | |
2021-10-05 | 2021-10-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
100
-1.4%
166.1916,619 USD |
100 -1.4% | 166.19 | 16,619 USD | |
2021-10-05 | 2021-10-01 |
Novavax Inc
(NVAX)
|
PS Planned sale |
400
-5.2%
165.4066,158 USD |
400 -5.2% | 165.40 | 66,158 USD | |
2021-09-17 | 2021-09-15 |
Novavax Inc
(NVAX)
|
PS Planned sale |
262
-27.1%
234.9061,543 USD |
262 -27.1% | 234.90 | 61,543 USD | |
2021-09-17 | 2021-09-15 |
Novavax Inc
(NVAX)
|
PS Planned sale |
300
-23.7%
232.5769,771 USD |
300 -23.7% | 232.57 | 69,771 USD | |
2021-09-17 | 2021-09-15 |
Novavax Inc
(NVAX)
|
PS Planned sale |
1,112
-46.7%
231.91257,882 USD |
1,112 -46.7% | 231.91 | 257,882 USD | |
2021-09-17 | 2021-09-15 |
Novavax Inc
(NVAX)
|
PS Planned sale |
500
-17.4%
230.52115,260 USD |
500 -17.4% | 230.52 | 115,260 USD | |
2021-09-17 | 2021-09-15 |
Novavax Inc
(NVAX)
|
PS Planned sale |
800
-21.7%
229.57183,655 USD |
800 -21.7% | 229.57 | 183,655 USD | |
2021-09-17 | 2021-09-15 |
Novavax Inc
(NVAX)
|
PS Planned sale |
300
-7.5%
228.2268,466 USD |
300 -7.5% | 228.22 | 68,466 USD | |
2021-09-17 | 2021-09-15 |
Novavax Inc
(NVAX)
|
PS Planned sale |
520
-11.6%
227.34118,217 USD |
520 -11.6% | 227.34 | 118,217 USD | |
2021-09-17 | 2021-09-15 |
Novavax Inc
(NVAX)
|
PS Planned sale |
906
-16.8%
226.34205,061 USD |
906 -16.8% | 226.34 | 205,061 USD | |
2021-09-17 | 2021-09-15 |
Novavax Inc
(NVAX)
|
PS Planned sale |
200
-3.6%
224.9444,987 USD |
200 -3.6% | 224.94 | 44,987 USD | |
2021-09-17 | 2021-09-15 |
Novavax Inc
(NVAX)
|
PS Planned sale |
100
-1.8%
223.5122,351 USD |
100 -1.8% | 223.51 | 22,351 USD | |
2021-07-28 | 2021-07-26 |
Novavax Inc
(NVAX)
|
PS Planned sale |
68
-8.8%
204.5713,911 USD |
68 -8.8% | 204.57 | 13,911 USD | |
2021-07-28 | 2021-07-26 |
Novavax Inc
(NVAX)
|
PS Planned sale |
58
-7.0%
203.4511,800 USD |
58 -7.0% | 203.45 | 11,800 USD | |
2021-07-28 | 2021-07-26 |
Novavax Inc
(NVAX)
|
PS Planned sale |
129
-13.4%
202.5826,132 USD |
129 -13.4% | 202.58 | 26,132 USD | |
2021-07-28 | 2021-07-26 |
Novavax Inc
(NVAX)
|
PS Planned sale |
209
-17.9%
201.5642,126 USD |
209 -17.9% | 201.56 | 42,126 USD | |
2021-07-28 | 2021-07-26 |
Novavax Inc
(NVAX)
|
PS Planned sale |
256
-18.0%
200.4751,321 USD |
256 -18.0% | 200.47 | 51,321 USD | |
2021-07-28 | 2021-07-26 |
Novavax Inc
(NVAX)
|
PS Planned sale |
224
-13.6%
199.4744,680 USD |
224 -13.6% | 199.47 | 44,680 USD | |
2021-07-28 | 2021-07-26 |
Novavax Inc
(NVAX)
|
PS Planned sale |
317
-16.1%
198.2062,830 USD |
317 -16.1% | 198.20 | 62,830 USD | |
2021-07-28 | 2021-07-26 |
Novavax Inc
(NVAX)
|
PS Planned sale |
485
-19.8%
197.4795,773 USD |
485 -19.8% | 197.47 | 95,773 USD | |
2021-07-28 | 2021-07-26 |
Novavax Inc
(NVAX)
|
PS Planned sale |
313
-11.3%
196.1261,386 USD |
313 -11.3% | 196.12 | 61,386 USD | |
2021-07-28 | 2021-07-26 |
Novavax Inc
(NVAX)
|
PS Planned sale |
263
-8.7%
195.2951,361 USD |
263 -8.7% | 195.29 | 51,361 USD | |
2021-07-28 | 2021-07-26 |
Novavax Inc
(NVAX)
|
PS Planned sale |
423
-12.3%
194.2682,171 USD |
423 -12.3% | 194.26 | 82,171 USD | |
2021-07-28 | 2021-07-26 |
Novavax Inc
(NVAX)
|
PS Planned sale |
151
-4.2%
193.0929,156 USD |
151 -4.2% | 193.09 | 29,156 USD | |
2021-06-02 | 2021-05-28 |
Novavax Inc
(NVAX)
|
PS Planned sale |
70
-20.3%
153.4910,744 USD |
70 -20.3% | 153.49 | 10,744 USD | |
2021-06-02 | 2021-05-28 |
Novavax Inc
(NVAX)
|
PS Planned sale |
95
-21.6%
152.1114,450 USD |
95 -21.6% | 152.11 | 14,450 USD | |
2021-06-02 | 2021-05-28 |
Novavax Inc
(NVAX)
|
PS Planned sale |
240
-35.3%
151.0836,258 USD |
240 -35.3% | 151.08 | 36,258 USD |